High Definition Transcranial Direct Current Stimulation (HD-tDCS) for Refractory Epilepsy

Launched by ANHUI MEDICAL UNIVERSITY · Jan 24, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a treatment called High Definition Transcranial Direct Current Stimulation (HD-tDCS) for people with refractory epilepsy, which is a form of epilepsy that doesn’t respond well to usual medications. The goal is to see how effective and safe this treatment is, and to understand how it works in the brain. Researchers will observe the effects of this electrical stimulation on patients and track changes before and after the treatment.

To participate in this trial, individuals must be between the ages of 18 and 50, right-handed, and have a diagnosis of refractory epilepsy. They should not have any major neurological or mental health issues, past head injuries, or substance abuse problems. Participants will be asked to avoid smoking, drinking, or taking certain medications during the study. If you or someone you know meets these criteria and is interested in exploring a new treatment option for epilepsy, this trial may be a great opportunity to consider.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Clinical diagnosis of refractory epilepsy
• • Right-handed and aged 18-50 years old and primary school education or above;
• • No major neurological or mental illness, no head injury, alcohol dependence or drug dependence;
• • During the experiment, the subjects did not smoke, drink, get sick and take psychotropic drugs, and there were no major life events that caused mood changes.
• Exclusion Criteria:
• • organic brain injury, neurological diseases or serious physical diseases;
• • Have a history of substance abuse and drug dependence, or have used antipsychotic drugs in the past three months, and have serious suicidal tendencies;
• • There are contraindications for MRI or EEG or transcranial magnetic stimulation.